ISDA

Deposition Date 2019-01-14

Release Date 2019-02-20

Last Version Date 2024-11-06

Entry Detail

PDB ID:

6NNA

Keywords:

TRANSFERASE

Title:

Human Fatty Acid Synthase Psi/KR Tri-Domain with NADPH and Compound 22

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.26 Å

R-Value Free:

0.25

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Fatty acid synthase,Fatty acid synthase
Gene (Uniprot):FASN
Mutations:M1110Q,S1438A,P1524G,M1110Q,S1438A,P1524G
Chain IDs:A, B
Chain Length:660
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P49327 Pfam ID:PF08242, PF21149, PF08659 EC:2.3.1.39

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
CAF	A	CYS	modified residue

Ligand Molecules

EDO

KUA

NDP

Primary Citation

Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN).

Martin, M.W, Lancia Jr, D.R, Li, H, Schiller, S.E.R, Toms, A.V, Wang, Z, Bair, K.W, Castro, J, Fessler, S, Gotur, D, Hubbs, S.E, Kauffman, G.S, Kershaw, M, Luke, G.P, McKinnon, C, Yao, L, Lu, W, Millan, D.S.Show

Bioorg. Med. Chem. Lett. 29 1001 1006 (2019)

PMID: 30803804 DOI: 10.1016/j.bmcl.2019.02.012

Abstact

The discovery, structure-activity relationships, and optimization of a novel class of fatty acid synthase (FASN) inhibitors is reported. High throughput screening identified a series of substituted piperazines with structural features that enable interactions with many of the potency-driving regions of the FASN KR domain binding site. Derived from this series was FT113, a compound with potent biochemical and cellular activity, which translated into excellent activity in in vivo models.

Legend

Protein

Chemical

Disease

Primary Citation of related structures